Feline
Feline Chronic Gingivostomatitis: Clinical Management
Bottom line
Confirm the oral inflammatory pattern, support comfort and intake, and plan dental extraction with an explicit postoperative reassessment strategy. The clinical review identifies extraction as the mainstay of FCGS treatment, with medical support and selected immunomodulation for persistent disease. [1] Clinical improvement, complete remission and freedom from medication are separate outcomes.
Define the lesions before choosing treatment
FCGS involves inflammation beyond the gingiva into oral mucosa. The review describes painful ulcerative or proliferative lesions, diagnostic biopsy and the importance of assessing concurrent dental pathology radiographically. [1]
Record lesion distribution, photographs, pain behavior, weight trajectory, actual intake and previous interventions. Clarify whether a prior extraction was complete as intended and whether images and histopathology are available. Do not let the caregiver's description of a sore mouth substitute for a documented oral examination.
The feline food-dropping workup separates oral disease from pharyngeal or esophageal dysfunction. The jaw-tremor and oral-pain assessment addresses another presentation that does not itself establish stomatitis.
Plan extraction using the mouth in front of you
A retrospective series evaluated 95 cats treated with extraction. Some achieved complete resolution, others substantial improvement, and some showed little or no improvement. Extent of extraction was not associated with overall response, and many favorable outcomes required additional medical treatment. [2]
Discuss the intended extent with the dental service using lesion distribution, dental imaging and the condition of remaining teeth. A retrospective absence of association does not prove that partial-mouth and full-mouth procedures are interchangeable for every patient. Likewise, extraction should not be presented as a guaranteed medication-free cure.
Agree on specimen handling, dental imaging, postoperative support and the first reassessment before the procedure. Preserve a tooth-level record of what was removed and any remaining pathology so subsequent clinicians can distinguish persistent inflammation from an unresolved dental problem.
Treat comfort and intake as continuing clinical decisions
The review emphasizes analgesia throughout management; medical treatment is important around surgery and in refractory disease, but should not simply replace the extraction plan. [1]
Assess whether the cat is consuming enough rather than merely approaching the bowl. Reconcile medication delivery with oral discomfort and the caregiver's ability to administer treatment. Record the nutritional and hydration plan, tolerability and the findings that require earlier reassessment or referral.
Use comparable observations over time: lesion appearance, eating, grooming, social behavior and weight. Keep inflammation and pain as related but distinct measures. Persistent reluctance to eat should prompt a new assessment of the whole patient rather than an automatic increase in one medication.
Reassess persistent disease before immunomodulation
Lommer's randomized, placebo-controlled, double-blinded study evaluated cyclosporine in selected cats whose stomatitis persisted after extractions. Improvement in the disease-activity score favored treatment during the 6-week controlled period. Cats with important comorbidities or retroviral infection were excluded, and absorption varied substantially. [3]
That evidence supports a specialist discussion for a defined refractory population. It does not establish the same benefit before appropriate dental treatment, in every comorbid cat or with every formulation. The later follow-up and treatment changes were not blinded comparative evidence. [3]
Before selecting immunomodulation, review the original diagnosis, residual dental findings, current systemic health, infection risks and practical delivery. Specify the target, monitoring and what would count as inadequate response or unacceptable toxicity. Verify the product, indication and applicable extra-label prescribing requirements locally; no regimen should be copied from a study without those checks.
Require an indication for antimicrobial treatment
The clinical review describes limited, often transient antimicrobial benefit and reserves a role principally for acute circumstances or secondary infection. [1] Repeated courses should not become the default response to unresolved chronic mucosal inflammation.
State the suspected infectious problem and how it will be reassessed. Record previous antimicrobial exposure and the reason for any additional course. Avoid treating temporary improvement as proof that an infection was the primary driver of the entire syndrome.
Make follow-up distinguish improvement from remission
The extraction series categorized response rather than assuming every treated cat reached the same endpoint. [2] Use that distinction in communications: what has improved, what remains abnormal, which medications are still necessary and what the next intervention is intended to accomplish.
Send the referring practice the dental record, original images, tissue findings, pain and intake observations, treatment response and follow-up responsibilities. Maintain a route for prompt reassessment when eating, comfort or systemic health deteriorates. A persistent case deserves a reproducible clinical review rather than an indefinite sequence of empirical prescriptions.
Frequently Asked Questions
Does gingivitis alone establish FCGS?
No. The clinical review describes inflammation extending beyond the gingiva into other oral mucosa; lesion distribution and diagnostic assessment matter. [1]
Can oral radiographs change the treatment plan?
Yes. The review highlights concurrent periodontal disease, resorption and retained roots that require assessment during extraction planning. [1]
Does the extraction cohort prove full-mouth and partial-mouth surgery equivalent?
No. Extent was not associated with overall response in a retrospective series; that is not randomized equivalence. [2]
Does improvement after extraction mean no further treatment will be needed?
No. Many cats with favorable outcomes in the cohort also required extended medical management. [2]
Was the cyclosporine trial conducted in untreated cats before dental surgery?
No. It studied selected cats with persistent disease after premolar-molar or full-mouth extractions. [3]
Does the controlled trial establish lifelong remission from a short course?
No. The blinded comparison assessed a 6-week period; later observations were not blinded comparative evidence. [3]
Are repeated antibiotics a substitute for the extraction and reassessment plan?
No. The review describes limited, transient antimicrobial benefit and a role chiefly in acute settings or secondary infection. [1]
References
- Soltero-Rivera, Goldschmidt and Arzi. Feline chronic gingivostomatitis: current concepts in clinical management. Journal of Feline Medicine and Surgery. (2023)
- Jennings et al. Effect of tooth extraction on stomatitis in cats: 95 cases (2000-2013). Journal of the American Veterinary Medical Association. (2015)
- Lommer. Efficacy of Cyclosporine for Chronic, Refractory Stomatitis in Cats: A Randomized, Placebo-Controlled, Double-Blinded Clinical Study. Journal of Veterinary Dentistry. (2013)
Voyage Dispatch · thevoyage.ai/forvets/knowledge/feline-chronic-gingivostomatitis-management · published Nov 18, 2026 · verify dosing against the current formulary before prescribing
More clinical updates
Feline Food Dropping: Oral Pain and Dysphagia Localization
A phase-based workup for cats that drop food, separating prehension and mastication pain from pharyngeal dysfunction and esophageal return.
Read →Feline Jaw Tremor and Oral Pain: Diagnostic Workup
A clinician-facing framework for distinguishing prey chatter, painful oral disease, nausea-associated movements, focal seizures, tremorgenic toxicosis, and respiratory distress.
Read →Canine Appendicular Osteosarcoma: Staging and Treatment
Plan diagnostic sampling, staging, local control and systemic therapy for canine appendicular osteosarcoma while keeping study endpoints distinct.
Read →Canine IMHA: Diagnostic Workup and Test Interpretation
Confirm immune-mediated hemolysis, interpret washed agglutination and DAT findings, and investigate associations without assuming causation.
Read →